(Q39121067)

9 September 2017

title

p53siRNA therapy reduces cell proliferation, migration and induces apoptosis in triple negative breast cancer cells (English)

1 reference

9 September 2017

1 reference

1

Cornelia Braicu

1 reference

9 September 2017

3

Alexandru Irimie

1 reference

9 September 2017

Ioana Berindan-Neagoe

series ordinal

4

object named as

Ioana Berindan-Neagoe

1 reference

9 September 2017

Valentina Pileczki

2

1 reference

9 September 2017

publication date

4 June 2013

1 reference

Molecular and Cellular Biochemistry

9 September 2017

published in

1 reference

9 September 2017

volume

381

1 reference

9 September 2017

issue

1-2

1 reference

9 September 2017

page(s)

61-68

1 reference

Targeting p53 for Novel Anticancer Therapy

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

The p53 proto-oncogene can act as a suppressor of transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

Cancer-derived p53 mutants suppress p53-target gene expression--potential mechanism for gain of function of mutant p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

Stable suppression of tumorigenicity by virus-mediated RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

Strategies for silencing human disease using RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

p53 and breast cancer, an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

The p53 pathway in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

Mcl-1 integrates the opposing actions of signaling pathways that mediate survival and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

Apoptotic cell signaling in cancer progression and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

Inflammation and cancer: how hot is the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

Apoptosis: a review of programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

Anoikis, initiated by Mcl-1 degradation and Bim induction, is deregulated during oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

BNIPL-2, a novel homologue of BNIP-2, interacts with Bcl-2 and Cdc42GAP in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

A functional and regulatory network associated with PIP expression in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

Effector caspases and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

c-Rel deficiency increases caspase-4 expression and leads to ER stress and necrosis in EBV-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

Treatment with the pure antiestrogen faslodex (ICI 182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

The Bcl-2 apoptotic switch in cancer development and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1688-5

Analysis of p53-regulated gene expression patterns using oligonucleotide arrays

21 January 2018

1 reference

12 December 2020

Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.

1 reference

12 December 2020

Increased p53 mutation frequency during tumor progression--results from a breast cancer cohort

1 reference

12 December 2020

Interfering with cancer: a brief outline of advances in RNA interference in oncology

1 reference

12 December 2020

10.1007/S11010-013-1688-5

Identifiers

DOI

1 reference

9 September 2017

1 reference